4 analysts have expressed a variety of opinions on Cibus CBUS over the past quarter, offering a diverse set of opinions from bullish to bearish. In the table below, you'll find a summary of their ...

Cibus (CBUS) announced an agreement affirming its collaboration with RTDC Corporation Limited and Albaugh to provide Clethodim as part of Cibus’ weed management solution for U.S. rice farmers ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

On Tuesday, Jefferies adjusted its price target for Cibus (NASDAQ:CBUS), a biotechnology company specializing in gene editing for agriculture, reducing it to $5.00 from the previous $8.00.

Cibus (CBUS) announced an agreement affirming its collaboration with RTDC Corporation Limited and Albaugh to provide Clethodim as part of Cibus’ weed management solution for U.S. rice farmers ...

Cibus (CBUS) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of a loss of $0.90 per share. This compares to loss of $1.59 per share a year ago. These ...